IMBioBody OSImmune system ↗

IMMUNE / 10

Harmless input.
Costly response.

Allergy develops when immune memory targets an otherwise usually harmless substance. IgE-mediated reactions are important but not the only allergy mechanism, and asthma includes multiple inflammatory and nonallergic phenotypes.

01FIRST EXPOSURES · TYPE-2 MEMORY
BARRIER

Allergen crosses a susceptible interface

Pollen, food, venom, medicines, mites, animals, molds, occupational material, and other antigens enter distinct barrier tissues.

EPITHELIUM

Barrier alarms shape type-2 context

Epithelial cytokines and dendritic-cell activation can favor helper T-cell programs associated with allergy and barrier repair.

CD4 T CELL

Helper signals instruct B cells

Type-2-associated cytokines and cell contact support class switching toward IgE in susceptible contexts.

B CELL

Allergen-specific IgE is produced

Plasma cells secrete IgE that binds high-affinity FcεRI receptors on mast cells and basophils.

SENSITIZATION

Memory can exist without symptoms

Specific IgE or a positive test indicates sensitization but does not alone prove clinically important allergy.

02RE-EXPOSURE · IMMEDIATE AND LATE PHASES
CROSS-LINKING

Allergen activates armed mast cells

Multivalent allergen binds adjacent mast-cell IgE molecules, initiating rapid signaling and granule release.

HISTAMINE

Fast symptoms appear

Histamine can cause itch, hives, sneezing, vascular leak, nasal symptoms, gut effects, and selected smooth-muscle responses.

LIPID MEDIATORS

Leukotrienes and prostaglandins extend effects

Newly synthesized mediators contribute to bronchoconstriction, mucus, edema, and recruitment beyond the immediate granule phase.

LATE PHASE

Eosinophils and T cells arrive

Cytokines and chemokines recruit eosinophils and other cells that can sustain epithelial injury and reactivity for hours or days.

ANAPHYLAXIS

Multiple systems can fail rapidly

Airway swelling, bronchospasm, vasodilation, vascular leak, low pressure, and gastrointestinal symptoms can create a life-threatening emergency.

03ASTHMA AIRWAY · TREATMENT TARGETS
HYPERRESPONSIVENESS

Airways narrow too readily

Inflamed or sensitized airways contract excessively to allergens, infection, exercise, cold air, irritants, or other triggers.

BRONCHOCONSTRICTION

Smooth muscle raises resistance

Airway muscle contraction rapidly narrows caliber, especially affecting expiratory flow and producing uneven ventilation.

MUCUS + EDEMA

The lumen narrows further

Secretions, epithelial shedding, and wall swelling add obstruction while cough and clearance mechanisms change.

REMODELING

Repeated inflammation can alter structure

Smooth-muscle mass, basement-membrane-associated matrix, glands, vessels, and epithelial behavior can change over time.

ANTIHISTAMINE

One mediator can be blocked

H1 antihistamines reduce selected histamine symptoms but do not treat all asthma biology or substitute for emergency anaphylaxis care.

CONTROLLERS

Airway targets differ by phenotype

Inhaled corticosteroids, bronchodilators, leukotriene modifiers, and targeted biologics act at different stages and require an individualized plan.